(Q57860471)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Gilad Cohen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Michael J Zelefsky

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Pirus Ghadjar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Xin Pei

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

William Polkinghorn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Yoshiya Yamada

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Zachary S Zumsteg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Marisa A Kollmeier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

22 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

360-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?

5 March 2020

cites work

1 reference

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

21 January 2018

1 reference

High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial

21 January 2018

1 reference

Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer

21 January 2018

1 reference

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

21 January 2018

1 reference

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

21 January 2018

1 reference

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

21 January 2018

1 reference

Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer

21 January 2018

1 reference

A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

What dose of external-beam radiation is high enough for prostate cancer?

21 January 2018

1 reference

Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer

21 January 2018

1 reference

Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer

21 January 2018

1 reference

An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.

21 January 2018

1 reference

Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321

21 January 2018

1 reference

Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJU.12514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24447404%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference